Identification of amino acid residues required for Ras p21 target activation.
Open Access
- 1 August 1991
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 11 (8) , 3997-4004
- https://doi.org/10.1128/mcb.11.8.3997
Abstract
The Krev-1 gene has been shown to suppress ras-mediated transformation in vitro. Both ras and Krev-1 proteins have identical effector domains (ras residues 32 to 40), which are required for biological activity and for the interaction of Ras p21 with Ras GTPase-activating protein (GAP). In this study, five amino acid residues flanking the ras effector domain, which are not conserved with the Krev-1 protein, were shown to be required for normal protein-protein interactions and biological activity. The substitution of Krev-1 p21 residues 26, 27, 30, 31, and 45 with the corresponding amino acid residues from Ras p21 resulted in a Krev-1 protein which had ras function in both mammalian and yeast biological assays. Replacement of these residues in Ras p21 with the corresponding Krev-1 p21 amino acids resulted in ras proteins which were impaired biologically or reduced in their affinity for in vitro GAP binding. Evaluation of these mutant ras proteins have implications for Ras p21-GAP interactions in vivo.Keywords
This publication has 40 references indexed in Scilit:
- Preferential inhibition of the oncogenic form of RasH by mutations in the GAP binding/“effector” domainCell, 1991
- Stimulation of p21ras upon T-cell activationNature, 1990
- Three-dimensional structures of H-ras p21 mutants: Molecular basis for their inability to function as signal switch moleculesCell, 1990
- Inhibition of GTPase Activating Protein Stimulation of Ras-p21 GTPase by the K rev -1 Gene ProductScience, 1990
- Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformationNature, 1989
- All ras proteins are polyisoprenylated but only some are palmitoylatedCell, 1989
- The cytoplasmic protein GAP is implicated as the target for regulation by the ras gene productNature, 1988
- Three-Dimensional Structure of an Oncogene Protein: Catalytic Domain of Human c-H- ras P21Science, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- Differential activation of yeast adenylate cyclase by wild type and mutant RAS proteinsCell, 1985